Physical Address
304 North Cardinal St.
Dorchester Center, MA 02124
Pembrolizumab Approved With Chemotherapy for MPM
Pembrolizumab (Keytruda, Merck) has picked up another indication — this time for the first-line treatment of unresectable advanced or metastatic malignant pleural mesothelioma (MPM) in combination with pemetrexed and platinum chemotherapy. With the US Food and Drug Administration’s September 17…
English